These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
613 related items for PubMed ID: 9414541
1. Diagnosis, management and screening of early localised prostate cancer. Selley S, Donovan J, Faulkner A, Coast J, Gillatt D. Health Technol Assess; 1997; 1(2):i, 1-96. PubMed ID: 9414541 [Abstract] [Full Text] [Related]
2. Prevalence of prostate cancer in aging males receiving PSA (prostate specific antigen) screening test (A campaign for celebration of Siriraj Established Day). Srinualnad S, Charoenkraikamol C, Toraksa S, Uiprasertkul M, Amornvesukit T, Taweemonkongsap T, Udompunturak S, Nualyong C, Tantiwong A. J Med Assoc Thai; 2006 Jan; 89(1):37-42. PubMed ID: 16583579 [Abstract] [Full Text] [Related]
3. Screening for prostate cancer: updated experience from the Tyrol study. Horninger W, Berger A, Pelzer A, Klocker H, Oberaigner W, Schönitzer D, Severi G, Robertson C, Boyle P, Bartsch G. Can J Urol; 2005 Feb; 12 Suppl 1():7-13; discussion 92-3. PubMed ID: 15780158 [Abstract] [Full Text] [Related]
4. Digital rectal examination is no longer necessary in the routine follow-up of men with undetectable prostate specific antigen after radical prostatectomy: the implications for follow-up. Chaplin BJ, Wildhagen MF, Schroder FH, Kirkels WJ, Bangma CH. Eur Urol; 2005 Dec; 48(6):906-10. PubMed ID: 16126322 [Abstract] [Full Text] [Related]
5. Potentially advanced malignancies detected by screening for prostate carcinoma after an interval of 4 years. Postma R, Roobol M, Schröder FH, van der Kwast TH. Cancer; 2004 Mar 01; 100(5):968-75. PubMed ID: 14983492 [Abstract] [Full Text] [Related]
6. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men. Agalliu I, Weiss NS, Lin DW, Stanford JL. Cancer Causes Control; 2007 Nov 01; 18(9):931-7. PubMed ID: 17641982 [Abstract] [Full Text] [Related]
7. [Screening for early detection of prostate cancer (first experience in Israel)]. Neheman A, Shotland Y, Metz Y, Stein A. Harefuah; 2001 Jan 01; 140(1):4-10, 88, 87. PubMed ID: 11242898 [Abstract] [Full Text] [Related]
8. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases. Freedland SJ, Sun L, Kane CJ, Presti JC, Terris MK, Amling CL, Moul JW, Aronson WJ. BJU Int; 2008 Sep 01; 102(8):969-74. PubMed ID: 18691175 [Abstract] [Full Text] [Related]
9. Cost-effectiveness of percent free PSA for prostate cancer detection in men with a total PSA of 4-10 ng/ml. Bermúdez-Tamayo C, Martín Martín JJ, González Mdel P, Pérez Romero C. Urol Int; 2007 Sep 01; 79(4):336-44. PubMed ID: 18025853 [Abstract] [Full Text] [Related]
10. Prostate biopsy: who, how and when. An update. Djavan B, Milani S, Remzi M. Can J Urol; 2005 Feb 01; 12 Suppl 1():44-8; discussion 99-100. PubMed ID: 15780165 [Abstract] [Full Text] [Related]
11. Prostate cancer in Victoria in 1993: patterns of reported management. Frydenberg M, Giles GG, Mameghan H, Thursfield VJ, Millar J, Wheelahan JB, Bolton DM, Syme RR. Med J Aust; 2000 Mar 20; 172(6):270-4. PubMed ID: 10860092 [Abstract] [Full Text] [Related]
12. Screening and early detection for prostate cancer. Magoha GA. East Afr Med J; 1997 Oct 20; 74(10):664-7. PubMed ID: 9529752 [Abstract] [Full Text] [Related]
13. The Japanese guideline for prostate cancer screening. Hamashima C, Nakayama T, Sagawa M, Saito H, Sobue T. Jpn J Clin Oncol; 2009 Jun 20; 39(6):339-51. PubMed ID: 19346535 [Abstract] [Full Text] [Related]
14. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer. Wilt TJ, Brawer MK, Barry MJ, Jones KM, Kwon Y, Gingrich JR, Aronson WJ, Nsouli I, Iyer P, Cartagena R, Snider G, Roehrborn C, Fox S. Contemp Clin Trials; 2009 Jan 20; 30(1):81-7. PubMed ID: 18783735 [Abstract] [Full Text] [Related]
15. PSA testing and DRE, TRUS scanning with sector biopsy, improved histology, curative treatments, and active surveillance for prostate cancer: a success story for men's health. Smart R. N Z Med J; 2008 Dec 12; 121(1287):57-68. PubMed ID: 19098969 [Abstract] [Full Text] [Related]
16. The prevalence of prostate cancer screening in Thai elderly. Tantiwong A, Soontrapa S, Sujijantrarat P, Vanprapar N, Sawangsak L. J Med Assoc Thai; 2002 Apr 12; 85(4):502-8. PubMed ID: 12118499 [Abstract] [Full Text] [Related]
17. Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC). Schröder FH. Can J Urol; 2005 Feb 12; 12 Suppl 1():2-6; discussion 92-3. PubMed ID: 15780157 [Abstract] [Full Text] [Related]
18. [Prostate-specific antigen in the diagnosis of organ-confined treatable prostate carcinoma]. Recker F. Schweiz Med Wochenschr; 1996 Nov 02; 126(44):1881-90. PubMed ID: 8984601 [Abstract] [Full Text] [Related]
19. Characteristics of prostate cancer detected by digital rectal examination only. Okotie OT, Roehl KA, Han M, Loeb S, Gashti SN, Catalona WJ. Urology; 2007 Dec 02; 70(6):1117-20. PubMed ID: 18158030 [Abstract] [Full Text] [Related]
20. [Adenocarcinoma of the prostate]. Dvorácek J. Cas Lek Cesk; 1998 Aug 31; 137(17):515-21. PubMed ID: 9787503 [Abstract] [Full Text] [Related] Page: [Next] [New Search]